Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus

被引:176
作者
Blomberg, S
Eloranta, ML
Cederblad, B
Nordlind, K
Alm, GV
Rönnblom, L
机构
[1] Uppsala Univ, Dept Med Sci, Rheumatol Sect, Uppsala, Sweden
[2] SLU, Dept Vet Microbiol, Immunol Sect, Uppsala, Sweden
[3] Uppsala Univ, Dept Med Sci, Sect Dermatol & Venereol, Uppsala, Sweden
[4] Karolinska Hosp, Dept Med, Unit Dermatol & Venereol, S-10401 Stockholm, Sweden
关键词
lupus; type IIFN; skin; rash;
D O I
10.1191/096120301678416042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) patients have increased levels of interferon-alfa (IFN-alpha) in the circulation but a reduced number of functionally intact natural IFN-a producing cells (IPC) in peripheral blood. In search for tissue localisation of activated IPC, we investigated skin biopsies from SLE patients for the occurrence of such cells. Eleven SLE patients with inflammatory skin lesions and six healthy controls were biopsied. An immunohistochemical technique OH) and in situ hybridisation (ISH) were used to detect intracellular IFN-alpha protein and IFN-alpha mRNA, respectively. In all 11 biopsies from SLE lesions, a high number of IPC were detected by IH. In the nonlesional SLE biopsies we could also demonstrate IPC in 10/11 patients. In 6/11 SLE patients, IFN-alpha mRNA containing cells could be detected in the specimens. A low number of IPC were detected in 1/6 healthy controls by IH, but no ISH positive cells were seen. Our results demonstrate that SLE patients have active IPC in both dermal lesions and in noninflammatory skin. A recruitment of IPC from blood to peripheral tissues may explain the low number of circulating natural IPC in SLE patients. Because the type I IFN system is involved in the SLE disease process, these results are of interest for the understanding of the pathogenesis in SLE.
引用
收藏
页码:484 / 490
页数:7
相关论文
共 34 条
[1]   IFN-α and IFN-β: A link between immune memory and chronic inflammation [J].
Akbar, AN ;
Lord, JM ;
Salmon, M .
IMMUNOLOGY TODAY, 2000, 21 (07) :337-+
[2]  
ALMASRI AN, 1996, EUROPEAN CYTOKINE NE, V7, P560
[3]   The combination of apoptotic U937 cells and lupus IgG is a potent IFN-α inducer [J].
Båve, U ;
Alm, GV ;
Rönnblom, L .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3519-3526
[4]  
BAVE U, IN PRESS J AUTOIMMUN
[5]   The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372
[6]   ROLE OF INTERFERONS AND OTHER CYTOKINES IN THE REGULATION OF THE IMMUNE-RESPONSE [J].
BELARDELLI, F .
APMIS, 1995, 103 (03) :161-179
[7]   Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies [J].
Bengtsson, AA ;
Sturfelt, G ;
Truedsson, L ;
Blomberg, J ;
Alm, G ;
Vallin, H ;
Rönnblom, L .
LUPUS, 2000, 9 (09) :664-671
[8]   The function of type I interferons in antimicrobial immunity [J].
Bogdan, C .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :419-424
[9]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[10]   Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-α-producing cells [J].
Cederblad, B ;
Blomberg, S ;
Vallin, H ;
Perers, A ;
Alm, GV ;
Ronnblom, L .
JOURNAL OF AUTOIMMUNITY, 1998, 11 (05) :465-470